Comparison of a nurse initiated insulin infusion protocol for intensive insulin therapy between adult surgical trauma, medical and coronary care intensive care patients

被引:13
作者
Barth M.M. [1 ]
Oyen L.J. [2 ]
Warfield K.T. [1 ]
Elmer J.L. [1 ]
Evenson L.K. [1 ]
Tescher A.N. [1 ]
Kuper P.J. [2 ]
Bannon M.P. [3 ]
Gajic O. [4 ]
Farmer J.C. [4 ]
机构
[1] Department of Nursing, Mayo Clinic, Rochester, MN
[2] Pharmacy Services, Mayo Clinic, Rochester, MN
[3] Department of Surgery, Mayo Clinic, Rochester, MN
[4] Department of Medicine, Mayo Clinic, Rochester, MN
关键词
Blood Glucose; Intensive Insulin Therapy; Coronary Care Unit; Blood Glucose Measurement; Goal Range;
D O I
10.1186/1471-227X-7-14
中图分类号
学科分类号
摘要
Background: Sustained hyperglycemia is a known risk factor for adverse outcomes in critically ill patients. The specific aim was to determine if a nurse initiated insulin infusion protocol (IIP) was effective in maintaining blood glucose values (BG) within a target goal of 100 - 150 mg/dL across different intensive care units (ICUs) and to describe glycemic control during the 48 hours after protocol discontinuation. Methods: A descriptive, retrospective review of 366 patients having 28,192 blood glucose values in three intensive care units, Surgical Trauma Intensive Care Unit (STICU), Medical (MICU) and Coronary Care Unit (CCU) in a quaternary care hospital was conducted. Patients were > 15 years of age, admitted to STICU (n = 162), MICU (n = 110) or CCU (n = 94) over 8 months; October 2003-June 2004 and who had an initial blood glucose level > 150 mg/dL. We summarized the effectiveness and safety of a nurse initiated IIP, and compared these endpoints among STICU, MICU and CCU patients. Results: The median blood glucose values (mg/dL) at initiation of insulin infusion protocol were lower in STICU (188; IQR, 162-217) than in MICU, (201; IQR, 170-268) and CCU (227; IQR, 178-313); p < 0.0001. Mean time to achieving a target glucose level (100-150 mg/dL) was similar between the three units: 4.6 hours in STICU, 4.7 hours in MICU and 4.9 hours in CCU (p = 0.27). Hypoglycemia (BG < 60 mg/dL) occurred in 7% of STICU, 5% of MICU, and 5% of CCU patients (p = 0.85). Protocol violations were uncommon in all three ICUs. Mean blood glucose 48 hours following IIP discontinuation was significantly different for each population: 142 mg/dL in STICU, 167 mg/dL in MICU, and 160 mg/dL in CCU (p < 0.0001). Conclusion: The safety and effectiveness of nurse initiated IIP was similar across different ICUs in our hospital. Marked variability in glucose control after the protocol discontinuation suggests the need for further research regarding glucose control in patients transitioning out of the ICU. © 2007 Barth et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 27 条
[1]  
Van den Berghe G., Wouter P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R., Intensive insulin therapy in critically ill patients, N Engl J Med, 345, pp. 1359-1367, (2001)
[2]  
Capes S.E., Hunt D., Malmberg K., Gersstein H.C., Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview, Lancet, 355, pp. 773-778, (2000)
[3]  
Malmberg K., Norhammar A., Wedel H., Ryden L., Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patient with diabetes mellitus and acute myocardial infarction long -term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study, Circulation, 99, pp. 2626-2632, (1999)
[4]  
Preiser J.C., Devos P., Van den Berghe G., Tight control of glycaemia in critically ill patients, Curr Opin Clin Nutr Metab Care, 5, pp. 533-537, (2002)
[5]  
McCowen K.C., Malhotra A., Bistrian B.R., Stress-induced hyperglycemia, Crit Care Clin, 17, pp. 107-124, (2001)
[6]  
Friere A.X., Bridges L., Umpierrez G.E., Kuhl D., Kitabchi A.E., Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population, Chest, 128, (2005)
[7]  
Whitcomb B.W., Pradhan E.K., Pittas A.G., Roghmann M.C., Perencevich E.N., Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations, Crit Care Med, 33, pp. 2772-2777, (2005)
[8]  
Pittas A.G., Siegel R.D., Lau J., Insulin therapy for critically ill hospitalized patients: A meta-analysis of randomized controlled trials, Arch Intern Med, 164, pp. 2005-2011, (2004)
[9]  
Van den Berghe G., Wouter P.J., Bouillon R., Weekers F., Verwaest C., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control, Crit Care Med, 31, pp. 359-366, (2003)
[10]  
Laird A.M., Miller P.R., Kilgo P.D., Meredith J.W., Chang M.C., Relationship of early hyperglycemia to mortality in trauma patients, J Trauma, 56, pp. 1058-1062, (2004)